Please Scroll Down to See Forums Below 
Jigga14
New member
So a certain board rep has been pushing nolva as the "miracle pct drug" on this board. We at Elite Fitness have outgrown the use for nolva long ago when we realized there were much better products out there that did a better job with less sides, and less FATAL SIDES. Now it seems that this certain rep wants to back up his "perfect pct" with some studies on tamoxifen that show its effectiveness. Yes it is effective to an extent, it is a breast cancer drug and selective estrogen receptor modulator, which prevents estrogen from binding to receptors. But it has documented other side effects, some of them FATAL. So if memebers wish to see some of the science behind why we don't support nolva, I have complied a few links for you all to read. The last one even goes to show how there were studies that were botched because they were paid off by the companies that were selling nolva. Its garbage, always has been, always will. There are much better options for PCT.
Thanks.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2867626/
http://www.livestrong.com/article/24977-permanent-side-effects-tamoxifen/
http://www.healthyhormones.com/news/news13.htm
http://www.aboutlawsuits.com/tamoxifen-side-effects-memory-cognitive-ability-8330/
http://healthmad.com/conditions-and-diseases/negative-effects-might-encourage-males-to-decrease-tamoxifen-with-regard-to-breast-cancer/
“However, tamoxifen exhibited two conflicting characteristics. It could act either as an anti-estrogen or as an estrogen. Therefore, while tamoxifen is anti-estrogenic to the breast, it also acts as an estrogen to the uterus and, to a lesser extent, the heart, blood vessels and bone. So, although it initially showed the tendency to counter breast cancer recurrence, it would soon be revealed that it also promoted particularly aggressive uterine and liver cancers, caused fatal blood clots and interfered with many other functions.” - http://www.all-natural.com/tamox.html
Swedish trial indicated a 400% increased risk of endometrial cancer for those 5 years on tamoxifen. With longer use the risk might be higher as "duration (of use) is more important than dosage" said Flora van Leeuwen of the Netherlands Cancer Institute. What she said is easy to understand: few smokers get cancer from tobacco in five years; it takes time. A five year study would probably pronounce nicotine as safe as nectarines. they want to dose us with Tamoxifen for life but only count the corpses for five years. The bottom line is that the longer you take this ""preventative" the more likely you are to die of cancer!
A March 1994 Journal of Clinical Oncology report showed that 67% of the tumors in tamoxifen users were "high-grade" compared to only 24% of endometrial cancers in other women, which works out to an 180% increase in bad tumors. For women with breast tumors who were later diagnosed with endometrial cancer the interval averaged 12 years for those who did not use Tamoxifen. This shortened to 5 years for users of the drug. Perhaps they should rename it TUMOR OFTEN!
R. J. Kedar of King's College School of Medicine and Dentistry in London studies 61 women in a tamoxifen trial and said: "Our study detected endometrial abnormalities at various times from THE FIRST TABLET OF TAMOXIFEN." The endometrium appeared abnormally thick in 24 of these women (39%) and 10 of these underwent potentially pre-cancerous changes. Science News reported that in this test only 5 of the 50 women given a placebo had an abnormal endometrium, and none showed the cell changes. The score was 10 to Zero against Tamoxifen. (Science News, June 4, 1994 - Study Reaffirms Tamoxifen's Dark Side).
Imperial Chemical Industries, with its affiliate Zeneca Group PLC got the National Cancer Institute to spring for a $68,000,000 "study" on 11,000 victims to procure a blessing on TAMOXIFEN as a "breast cancer preventative." Then Imperial cut a deal with the University of Pittsburgh to have Dr. Bernard Fisher lead the tests on healthy female volunteers. Imperial also cut a $600,000 check to the University of Pittsburgh in honor of Doc Fisher. No sense taking a chance the test results won't be good with billions$ at stake!
The tests began in 1992 without telling the women that Tamoxifen caused fatal endometrial cancer , serious eye damage and blood clots which can lead to strokes. The UP and Imperial knew this from an earlier 5 year test in which the Tamoxifen group developed 23 womb cancers while the untreated control group had only 2 such malignancies. SCORE: Tamoxifen cancer increase, 1,050%!
Imperial/Zeneca and U of P concealed these hazards from the volunteers in the 1993 test, fearing "potential negative publicity" (Let the women die!) / This is the same Zeneca that was being sued by the United States and the State of California for allegedly dumping DDT and PCBS into Los Angeles and Long Beach harbors. In June of 1993 they demerged from Imperial Chemical Industries. Zeneca also makes $300 million worth of carcinogenic herbicide called acetochlor every year. First they give us cancer with a poison, then they concoct another to treat us!
http://www.holisticmed.com/toxic/tamoxifen.shtml
Thanks.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2867626/
http://www.livestrong.com/article/24977-permanent-side-effects-tamoxifen/
http://www.healthyhormones.com/news/news13.htm
http://www.aboutlawsuits.com/tamoxifen-side-effects-memory-cognitive-ability-8330/
http://healthmad.com/conditions-and-diseases/negative-effects-might-encourage-males-to-decrease-tamoxifen-with-regard-to-breast-cancer/
“However, tamoxifen exhibited two conflicting characteristics. It could act either as an anti-estrogen or as an estrogen. Therefore, while tamoxifen is anti-estrogenic to the breast, it also acts as an estrogen to the uterus and, to a lesser extent, the heart, blood vessels and bone. So, although it initially showed the tendency to counter breast cancer recurrence, it would soon be revealed that it also promoted particularly aggressive uterine and liver cancers, caused fatal blood clots and interfered with many other functions.” - http://www.all-natural.com/tamox.html
Swedish trial indicated a 400% increased risk of endometrial cancer for those 5 years on tamoxifen. With longer use the risk might be higher as "duration (of use) is more important than dosage" said Flora van Leeuwen of the Netherlands Cancer Institute. What she said is easy to understand: few smokers get cancer from tobacco in five years; it takes time. A five year study would probably pronounce nicotine as safe as nectarines. they want to dose us with Tamoxifen for life but only count the corpses for five years. The bottom line is that the longer you take this ""preventative" the more likely you are to die of cancer!
A March 1994 Journal of Clinical Oncology report showed that 67% of the tumors in tamoxifen users were "high-grade" compared to only 24% of endometrial cancers in other women, which works out to an 180% increase in bad tumors. For women with breast tumors who were later diagnosed with endometrial cancer the interval averaged 12 years for those who did not use Tamoxifen. This shortened to 5 years for users of the drug. Perhaps they should rename it TUMOR OFTEN!
R. J. Kedar of King's College School of Medicine and Dentistry in London studies 61 women in a tamoxifen trial and said: "Our study detected endometrial abnormalities at various times from THE FIRST TABLET OF TAMOXIFEN." The endometrium appeared abnormally thick in 24 of these women (39%) and 10 of these underwent potentially pre-cancerous changes. Science News reported that in this test only 5 of the 50 women given a placebo had an abnormal endometrium, and none showed the cell changes. The score was 10 to Zero against Tamoxifen. (Science News, June 4, 1994 - Study Reaffirms Tamoxifen's Dark Side).
Imperial Chemical Industries, with its affiliate Zeneca Group PLC got the National Cancer Institute to spring for a $68,000,000 "study" on 11,000 victims to procure a blessing on TAMOXIFEN as a "breast cancer preventative." Then Imperial cut a deal with the University of Pittsburgh to have Dr. Bernard Fisher lead the tests on healthy female volunteers. Imperial also cut a $600,000 check to the University of Pittsburgh in honor of Doc Fisher. No sense taking a chance the test results won't be good with billions$ at stake!
The tests began in 1992 without telling the women that Tamoxifen caused fatal endometrial cancer , serious eye damage and blood clots which can lead to strokes. The UP and Imperial knew this from an earlier 5 year test in which the Tamoxifen group developed 23 womb cancers while the untreated control group had only 2 such malignancies. SCORE: Tamoxifen cancer increase, 1,050%!
Imperial/Zeneca and U of P concealed these hazards from the volunteers in the 1993 test, fearing "potential negative publicity" (Let the women die!) / This is the same Zeneca that was being sued by the United States and the State of California for allegedly dumping DDT and PCBS into Los Angeles and Long Beach harbors. In June of 1993 they demerged from Imperial Chemical Industries. Zeneca also makes $300 million worth of carcinogenic herbicide called acetochlor every year. First they give us cancer with a poison, then they concoct another to treat us!
http://www.holisticmed.com/toxic/tamoxifen.shtml
